Tiny Gem

Freight Technologies Inc. (NASDAQ: FRGT) Shares anticipated 0-200% Revenue Growth for 2023; Reports Highest Monthly Increase in New Clients during month of March

  • Fr8Tech’s management recently shared its updated 2023 revenue guidance of $25-30 million, representing as much as nearly 20% growth from the previous year’s full-year revenue
  • The growth will be fueled, in part, by the uptake of its services, with the company having posted the highest monthly increase in new client sign-ups since the launch of the Fr8App platform
  • Following the recent 10 to 1 reverse share split necessary for Fr8Tech to regain Nasdaq compliance, the company showed that the price would need to show 11x growth on the closing price of March 28, 2023 to meet with third party forecasts for the company
  • Fr8Tech remains committed to revolutionizing cross-border shipping, and the recent increase in new client sign-ups is indicative of the building momentum, and potential of its products and services

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company on a mission to revolutionize cross-border shipping by offering carriers increased growth opportunities and shippers with flexibility, visibility, and simplicity, is working hard to have its best year yet. The company’s management recently updated its 2023 revenue guidance of $25-30 million, representing up to nearly 20% growth from the previous year’s full-year revenue (https://ibn.fm/XvYo4) in a very difficult freight market.

This growth will be fueled, in part, by the uptake of its services, with the company having posted the highest monthly increase in new clients since the launch of its Fr8App platform. According to Fr8Tech’s Sales Director, Harry Martin, the new sign-ups were expected to yield a recurring monthly income of over $1 million a month, with the figure expected to start growing in Q2 and through the rest of the year.

“We have onboarded new clients in a variety of sectors, including automotive, beverage, motorcycles, and consumer goods that we had been working on for some time,” noted Mr. Martin.

“The new shipper clients represent a potential for significant recurring traffic on our platform and include leading first-tier automotive clients,” he added.

On March 7, 2023, Fr8Tech announced quarterly revenue for Q4 2022 amounting to $4.4 million. The company also reported a year-to-date (“YTD”) 2022 revenue of an impressive $25.9, representing a 20.6% growth from the previous year. Its management is optimistic that the current momentum will be maintained, yielding even more significant growth as time progresses and more value for its shareholders.

This performance will be very welcome, particularly following the recent 10 to 1 reverse share split necessary for Fr8Tech to regain Nasdaq compliance. As of the close of market on March 31, 2023, this share split saw the share price stand at $1.560, a 92.2% discount to independent analysts’ target price for the company’s ordinary shares of $20 per share on a split-adjusted basis. On the upside, it implied an over 11x growth on the closing price of March 28, 2023.

Fr8Tech remains committed to revolutionizing cross-border shipping, and the recent increase in new client sign-ups indicates the building momentum and potential of its products and services. As it looks forward to a successful year 2023, Fr8Tech continues to strengthen its brand, bolster its offerings, and increase incentives toward its customers. It is a company committed to its mission, taking on a once-complex process of international over-the-road shipping and simplifying it for the ordinary customer.

For more information, visit the company’s website at www.Fr8Technologies.com, and its freight matching platform information site at www.Fr8.App.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

About TinyGems

TinyGems is your guide to the best and brightest in the under-appreciated small-cap sector. As one of 50+ brands within the InvestorBrandNetwork (“IBN”), TinyGems provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to reach millions of social media followers; and (5) a full array of corporate communications solutions. It’s time to uncover some of the best-kept secrets on Wall Street. TinyGems features innovative small-cap companies with huge potential, putting a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios. Whether it’s a game changing technology, a new more profitable product or service, or a star in a hot sector, TinyGems is the go-to source for actionable intelligence.

To receive SMS text alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, California
www.TinyGems.com
310.299.1717 Office
Editor@TinyGems.com

TinyGems is part of the InvestorBrandNetwork

Christian Amiscua

Share
Published by
Christian Amiscua

Recent Posts

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Focused on Dual Narratives of Scientific Progress, Social Engagement

LIXTE recently announced advances in its approach to cancer therapy through its proprietary compound LB-100 Alongside…

2 days ago

New AI Model Predicts Dementia Risk, Cancer Survival and Brain Age

Mass General Brigham researchers have developed a new AI model that can estimate brain age, assess a patient’s risk of…

4 days ago

Investors React Positively to Meta’s Plan to Increase AI Capex

Investors are responding positively to Meta’s decision to keep increasing artificial intelligence spending, even as fears grow…

6 days ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Aligns Liora and the LiGHT System With LB-100 to Push the Frontier of Cancer Treatment

LIXTE Biotechnology recently acquired Liora Technologies, and the acquisition includes Liora’s proprietary LiGHT system This…

6 days ago

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

LIXTE’s lead compound, LB-100, targets PP2A, a central regulator of cancer cell survival and treatment…

1 week ago

Scientists Discover Why Immunotherapy Frequently Fails

Although cancer immunotherapy has transformed treatment for many patients, the promise of effective immunotherapy falls short for many…

2 weeks ago